WIN-Partners CoTSE:3183 +0.31%63 Median PS Value is 円1,531.95 as of Jul. 09, 2026, which is 100% below its 10-year median of 0.97. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 70 Medical Distribution companies, WIN-Partners Co ranks worse than 52.86% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. WIN-Partners Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円3255.898. WIN-Partners Co's 10-Year median PS Ratio is 0.4705. Therefore, the Median PS Value for today is 円1,531.95.
As of today (2026-07-09), WIN-Partners Co's share price is 円1285.00. WIN-Partners Co's Median PS Value is 円1,531.95. Therefore, WIN-Partners Co's Price to Median PS Value for today is 0.84.
The historical rank and industry rank for WIN-Partners Co's Median PS Value or its related term are showing as below:
TSE:3183'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.81 Med: 0.97 Max: 2.22
Current: 0.84
During the past 13 years, the highest Price to Median PS Value of WIN-Partners Co was 2.22. The lowest was 0.81. And the median was 0.97.
TSE:3183's Price-to-Median-PS-Value is ranked worse than 52.86% of 70
companies
in the Medical Distribution industry
Industry Median: 0.83
vs TSE:3183: 0.84
WIN-Partners Co (TSE:3183) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
WIN-Partners Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1285.00
/
1,531.95
=
0.84
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WIN-Partners Co Median PS Value Related Terms
WIN-Partners Co Median PS Value Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3183 vs MCK, CAH, COR: Median PS Value Comparison
For the Medical Distribution subindustry, WIN-Partners Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.4705.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WIN-Partners Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円3255.898.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WIN-Partners Co (TSE:3183) has a Median PS Value of 円1,531.95 as of Jul. 09, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on WIN-Partners Co and its competitors. This is 157833% above median its historical median of 0.97. Over the past decade, WIN-Partners Co's Median PS Value has ranged from 0.81 to 2.22. According to the industry distribution chart, WIN-Partners Co ranks #37 out of 70 companies in the Medical Distribution industry, placing it in the top 52.9%.
Is WIN-Partners Co's Median PS Value too high?
WIN-Partners Co's current Median PS Value of 円1,531.95 is 157833% above median its 10-year median of 0.97. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 2.22. Based on the distribution chart, WIN-Partners Co ranks #37 out of 70 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's Median PS Value compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #37 out of 70 companies for Median PS Value. This places WIN-Partners Co in the lower half of its industry. The industry median Median PS Value is 0.83. Historically, WIN-Partners Co's own Median PS Value has ranged from 0.81 to 2.22 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.83, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current Median PS Value is 円1,531.95, which is 157833% above median its own 10-year median of 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current Median PS Value is 円1,531.95, which is 157833% above median its 10-year median of 0.97. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current Median PS Value is 円1,531.95 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
Median PS Value: 円1,531.95 (157833% above median its 10-year median of 0.97)
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
